Ads
related to: abbvie
Search results
Why Investors Are Eyeing AbbVie Inc (ABBV): The Key Drivers of M
Guru Focus· 3 days agoAbbVie Inc (ABBV, Financial) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial performance and promising growth ...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 4 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Valley City Times Record· 3 days agoReents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical ...
One of AbbVie's post-Humira hopefuls gets closer to clearing hurdle in Europe
Crain s Chicago Business· 6 days agoAbbVie has received good news from the European Medicines Agency for a new use of its anti-inflammation drug Skyrizi, one of the best-selling products in its portfolio, now ...
Halozyme's (HALO) ENHANZE Product Gets New Patent Grant in EU
Zacks via Yahoo Finance· 3 hours agoHalozyme (HALO) is set to benefit from the new patent grant in the EU, ensuring the protection of...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with...
telegraphherald.com· 6 days agoThe positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated the efficacy and safety of risankizumab in adults with moderately to severely
Hedge Fund Favorites: 7 Stocks to Buy When You're Feeling Jittery
InvestorPlace· 6 hours agoWith the market entering a historically challenging season (due to the adage buy in May and go...
Believe And Two More Euronext Paris Growth Stocks With Major Insider Ownership
Simply Wall St. via Yahoo Finance· 2 hours agoAs the French CAC 40 Index experiences a downturn, reflecting broader European market sensitivities...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates | JD Supra
JD Supra· 9 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating number of U.S. Food and Drug Administration (FDA) approvals and rapidly growing market size, as ...
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
InvestorPlace· 18 hours agoOne of the most important sectors globally, it is hard to imagine life without biotech companies...
Ad
related to: abbvie